Evidence map›Paper›PMID 23114595›Full record

ArticleThe Journal of clinical investigation2012

Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome.

Nayia Nicolaou, Coert Margadant, Sietske H Kevelam, Marc R Lilien, Michiel J S Oosterveld, Maaike Kreft, Albertien M van Eerde, Rolph Pfundt, Paulien A Terhal, Bert van der Zwaag and 6 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Cells · 2025
    Article
  7. Integrins in the kidney - beyond the matrix.Nature reviews. Nephrology · 2025
    Review
  8. The epidermal integrin-mediated secretome regulates the skin microenvironment during tumorigenesis and repair.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Review
  9. Review
  10. Article
  11. Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics.International journal of molecular sciences · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Nayia NicolaouDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Coert Margadant
Sietske H Kevelam
Marc R Lilien
Michiel J S Oosterveld
Maaike Kreft
Albertien M van Eerde
Rolph Pfundt
Paulien A Terhal
Bert van der Zwaag
Peter G J Nikkels
Norman Sachs
Roel Goldschmeding
Nine V A M Knoers
Kirsten Y Renkema
Arnoud Sonnenberg
University Medical Center Utrecht · NLThe Netherlands Cancer Institute · NLRadboud University Nijmegen · NLWilhelmina Children's Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrins are transmembrane αβ glycoproteins that connect the extracellular matrix to the cytoskeleton. The laminin-binding integrin α3β1 is expressed at high levels in lung epithelium and in kidney podocytes. In podocytes, α3β1 associates with the tetraspanin CD151 to maintain a functional filtration barrier. Here, we report on a patient homozygous for a novel missense mutation in the human ITGA3 gene, causing fatal interstitial lung disease and congenital nephrotic syndrome. The mutation caused an alanine-to-serine substitution in the integrin α3 subunit, thereby introducing an N-glycosylation motif at amino acid position 349. We expressed this mutant form of ITGA3 in murine podocytes and found that hyperglycosylation of the α3 precursor prevented its heterodimerization with β1, whereas CD151 association with the α3 subunit occurred normally. Consequently, the β1 precursor accumulated in the ER, and the mutant α3 precursor was degraded by the ubiquitin-proteasome system. Thus, these findings uncover a gain-of-glycosylation mutation in ITGA3 that prevents the biosynthesis of functional α3β1, causing a fatal multiorgan disorder.

Indexed as

Base SequenceCells, CulturedEndoplasmic ReticulumFatal OutcomeFemaleGene ExpressionGenetic Association StudiesGlomerular MesangiumGlycosylationHumansInfantIntegrin alpha3Integrin beta1Lung Diseases, InterstitialModels, MolecularNephrotic SyndromeCD151 protein, humanIntegrin alpha3Integrin beta1Proteasome Endopeptidase ComplexTetraspanin 24

Identifiers

PMID23114595
PMCPMC3533548
OpenAlexW2107606833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.